By Paul A. Harris
Portland, Ore., Feb. 11 – LifePoint Health, Inc. priced a $600 million issue of seven-year senior secured notes (B1/B+) at par to yield 4 3/8% in a Tuesday drive-by, according to market sources.
The yield printed at the tight end of yield talk in the 4½% area. Initial guidance had the notes coming to yield 4¾% to 5%.
The deal was six-times oversubscribed at 4¾%, according to a market source, who added that most investors remained in the deal when the 4½% area price talk came out.
Bookrunners were Barclays, Citigroup Global Markets Inc., RBC Capital Markets LLC, Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc. and Morgan Stanley & Co. LLC.
The Brentwood, Tenn.-based health care provider plans to use the proceeds, along with its incremental term loan B, to refinance its 8¼% senior secured notes due 2023 and its 11½% senior notes due 2024.
Issuer: | LifePoint Health, Inc.
|
Amount: | $600 million
|
Maturity: | Feb. 15, 2027
|
Securities: | Senior secured notes
|
Bookrunners: | Barclays, Citigroup Global Markets Inc., RBC Capital Markets LLC, Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc. and Morgan Stanley & Co. LLC
|
Co-manager: | Apollo Global Securities, LLC
|
Coupon: | 4 3/8%
|
Price: | Par
|
Yield: | 4 3/8%
|
Spread: | 287 bps
|
First call: | Feb. 15, 2022 at 102
|
Equity clawback: | 40% at 104.375 until Feb. 15, 2022
|
Trade date: | Feb. 11
|
Settlement date: | Feb. 13
|
Ratings: | Moody's: B1
|
| S&P: B+
|
Distribution: | Rule 144A and Regulation S for life
|
Price talk: | 4½% area
|
Marketing: | Drive-by
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.